- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/13 - B-cells
Patent holdings for IPC class A61K 40/13
Total number of patents in this class: 30
10-year publication summary
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2613 |
3 |
| Centre National de La Recherche Scientifique | 10641 |
2 |
| Institut Curie | 602 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2953 |
2 |
| Regents of the University of Minnesota | 2723 |
2 |
| Université Paris-saclay | 566 |
2 |
| Université Paris Cité | 832 |
2 |
| Massachusetts Institute of Technology | 10131 |
1 |
| Northwestern University | 3440 |
1 |
| The Broad Institute, Inc. | 1862 |
1 |
| Children's Medical Center Corporation | 1906 |
1 |
| Chimera Bioengineering, Inc. | 45 |
1 |
| The Cleveland Clinic Foundation | 1575 |
1 |
| Oslo Universitetssykehus HF | 190 |
1 |
| STEMCELL Technologies Canada Inc. | 287 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2895 |
1 |
| Universitetet I Oslo | 159 |
1 |
| The University of North Carolina at Chapel Hill | 2064 |
1 |
| Immunitybio, Inc. | 454 |
1 |
| Walking Fish Therapeutics, Inc. | 23 |
1 |
| Other owners | 2 |